Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Up 153.6% in March

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 76,600 shares, an increase of 153.6% from the February 28th total of 30,200 shares. Based on an average trading volume of 447,700 shares, the short-interest ratio is presently 0.2 days.

Ono Pharmaceutical Stock Performance

Shares of OPHLY stock traded down $0.02 during mid-day trading on Friday, hitting $3.64. 87,268 shares of the stock traded hands, compared to its average volume of 423,998. The stock’s fifty day moving average is $3.51 and its two-hundred day moving average is $3.82. Ono Pharmaceutical has a 52-week low of $3.21 and a 52-week high of $5.54.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.